Global Biosimilar of Remicade Market Size, Status and Forecast 2019-2025

Published On: Jun 2019

Format: PDF

Publisher: QY Research

Pages: 92

Report ID: 1365

Biosimilar can be defined as a type of biological product that is highly similar to an already FDA approved drug, known as reference biological product. 
In 2018, the global Biosimilar of Remicade market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Biosimilar of Remicade status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Biosimilar of Remicade development in United States, Europe and China.

The key players covered in this study
Synthon Pharmaceuticals
LG Life Sciences
Novartis (Sandoz)
Celltrion
Biocon
Hospira
Merck Serono (Merck Group)
Biogen idec Inc.
Genentech (Roche Group)

Market segment by Type, the product can be split into
100mg/10ml
500mg/50ml

Market segment by Application, split into
Blood Disorders
Oncology Diseases

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Biosimilar of Remicade status, future forecast, growth opportunity, key market and key players.
To present the Biosimilar of Remicade development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Biosimilar of Remicade are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Biosimilar of Remicade Market Size Growth Rate by Type (2014-2025)
1.4.2 100mg/10ml
1.4.3 500mg/50ml
1.5 Market by Application
1.5.1 Global Biosimilar of Remicade Market Share by Application (2014-2025)
1.5.2 Blood Disorders
1.5.3 Oncology Diseases
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Biosimilar of Remicade Market Size
2.2 Biosimilar of Remicade Growth Trends by Regions
2.2.1 Biosimilar of Remicade Market Size by Regions (2014-2025)
2.2.2 Biosimilar of Remicade Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Biosimilar of Remicade Market Size by Manufacturers
3.1.1 Global Biosimilar of Remicade Revenue by Manufacturers (2014-2019)
3.1.2 Global Biosimilar of Remicade Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Biosimilar of Remicade Market Concentration Ratio (CR5 and HHI)
3.2 Biosimilar of Remicade Key Players Head office and Area Served
3.3 Key Players Biosimilar of Remicade Product/Solution/Service
3.4 Date of Enter into Biosimilar of Remicade Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Biosimilar of Remicade Market Size by Type (2014-2019)
4.2 Global Biosimilar of Remicade Market Size by Application (2014-2019)

5 United States
5.1 United States Biosimilar of Remicade Market Size (2014-2019)
5.2 Biosimilar of Remicade Key Players in United States
5.3 United States Biosimilar of Remicade Market Size by Type
5.4 United States Biosimilar of Remicade Market Size by Application

6 Europe
6.1 Europe Biosimilar of Remicade Market Size (2014-2019)
6.2 Biosimilar of Remicade Key Players in Europe
6.3 Europe Biosimilar of Remicade Market Size by Type
6.4 Europe Biosimilar of Remicade Market Size by Application

7 China
7.1 China Biosimilar of Remicade Market Size (2014-2019)
7.2 Biosimilar of Remicade Key Players in China
7.3 China Biosimilar of Remicade Market Size by Type
7.4 China Biosimilar of Remicade Market Size by Application

8 Japan
8.1 Japan Biosimilar of Remicade Market Size (2014-2019)
8.2 Biosimilar of Remicade Key Players in Japan
8.3 Japan Biosimilar of Remicade Market Size by Type
8.4 Japan Biosimilar of Remicade Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Biosimilar of Remicade Market Size (2014-2019)
9.2 Biosimilar of Remicade Key Players in Southeast Asia
9.3 Southeast Asia Biosimilar of Remicade Market Size by Type
9.4 Southeast Asia Biosimilar of Remicade Market Size by Application

10 India
10.1 India Biosimilar of Remicade Market Size (2014-2019)
10.2 Biosimilar of Remicade Key Players in India
10.3 India Biosimilar of Remicade Market Size by Type
10.4 India Biosimilar of Remicade Market Size by Application

11 Central & South America
11.1 Central & South America Biosimilar of Remicade Market Size (2014-2019)
11.2 Biosimilar of Remicade Key Players in Central & South America
11.3 Central & South America Biosimilar of Remicade Market Size by Type
11.4 Central & South America Biosimilar of Remicade Market Size by Application

12 International Players Profiles
12.1 Synthon Pharmaceuticals
12.1.1 Synthon Pharmaceuticals Company Details
12.1.2 Company Description and Business Overview
12.1.3 Biosimilar of Remicade Introduction
12.1.4 Synthon Pharmaceuticals Revenue in Biosimilar of Remicade Business (2014-2019)
12.1.5 Synthon Pharmaceuticals Recent Development
12.2 LG Life Sciences
12.2.1 LG Life Sciences Company Details
12.2.2 Company Description and Business Overview
12.2.3 Biosimilar of Remicade Introduction
12.2.4 LG Life Sciences Revenue in Biosimilar of Remicade Business (2014-2019)
12.2.5 LG Life Sciences Recent Development
12.3 Novartis (Sandoz)
12.3.1 Novartis (Sandoz) Company Details
12.3.2 Company Description and Business Overview
12.3.3 Biosimilar of Remicade Introduction
12.3.4 Novartis (Sandoz) Revenue in Biosimilar of Remicade Business (2014-2019)
12.3.5 Novartis (Sandoz) Recent Development
12.4 Celltrion
12.4.1 Celltrion Company Details
12.4.2 Company Description and Business Overview
12.4.3 Biosimilar of Remicade Introduction
12.4.4 Celltrion Revenue in Biosimilar of Remicade Business (2014-2019)
12.4.5 Celltrion Recent Development
12.5 Biocon
12.5.1 Biocon Company Details
12.5.2 Company Description and Business Overview
12.5.3 Biosimilar of Remicade Introduction
12.5.4 Biocon Revenue in Biosimilar of Remicade Business (2014-2019)
12.5.5 Biocon Recent Development
12.6 Hospira
12.6.1 Hospira Company Details
12.6.2 Company Description and Business Overview
12.6.3 Biosimilar of Remicade Introduction
12.6.4 Hospira Revenue in Biosimilar of Remicade Business (2014-2019)
12.6.5 Hospira Recent Development
12.7 Merck Serono (Merck Group)
12.7.1 Merck Serono (Merck Group) Company Details
12.7.2 Company Description and Business Overview
12.7.3 Biosimilar of Remicade Introduction
12.7.4 Merck Serono (Merck Group) Revenue in Biosimilar of Remicade Business (2014-2019)
12.7.5 Merck Serono (Merck Group) Recent Development
12.8 Biogen idec Inc.
12.8.1 Biogen idec Inc. Company Details
12.8.2 Company Description and Business Overview
12.8.3 Biosimilar of Remicade Introduction
12.8.4 Biogen idec Inc. Revenue in Biosimilar of Remicade Business (2014-2019)
12.8.5 Biogen idec Inc. Recent Development
12.9 Genentech (Roche Group)
12.9.1 Genentech (Roche Group) Company Details
12.9.2 Company Description and Business Overview
12.9.3 Biosimilar of Remicade Introduction
12.9.4 Genentech (Roche Group) Revenue in Biosimilar of Remicade Business (2014-2019)
12.9.5 Genentech (Roche Group) Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details